ArticleInternal and emergency medicine2025
Lithium and smoking-associated scleroderma-like pattern in a 18-year-old patient: a case report.
Article in Internal and emergency medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This case report explores an 18-year-old female patient undergoing lithium therapy for bipolar disorder over four years, combined with a concurrent two-year history of smoking approximately 20 cigarettes daily. Over the past year, the patient exhibited acrocyanosis primarily affecting her hands, particularly following cold exposure. Capillaroscopic analysis in November 2024 revealed a "scleroderma-like pattern," marked by megacapillaries, architectural disorganization, and microhemorrhages. Comprehensive immunological testing, including antinuclear antibodies (ANA), anti-cardiolipin antibodies, and anti-phospholipid antibodies, returned negative results, with no clinical or laboratory evidence indicative of an underlying connective tissue disease (CTD). This case underscores the interplay of environmental and pharmacological contributors, such as smoking and lithium, to microvascular dysfunction, emphasizing the necessity of rigorous diagnostic assessments and mitigation of modifiable risk factors in patient care.
Indexed as
Identifiers
40382751What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.